Navigation Links
iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
Date:3/12/2008

ulatory Affairs, Clinical Affairs and Quality Assurance at Microsulis Americas, Inc., a medical device company that manufactures endometrial ablation systems for gynecological markets worldwide. Prior to that, he served as the Division Vice President of Quality Assurance for the Critical Care Division at Smiths Medical Critical Care, which develops and manufactures Class I and II anesthesia, respiratory, needle safety devices, and a wide variety of critical care devices. During his career he has also worked at companies such as ACMI Corporation, Genzyme, C.R. Bard and Pfizer.

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by more than 1800 women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.

For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com

For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 or via email at icad@lhai.com

For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770 or via email at icad@schwartz-pr.com

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Certain statements contained in this News Release, including but not limited to, statements about the Company's confidence or strategies or expectations about revenues, results of operations, timing of regulatory approval of products or market opportunities, consti
'/>"/>

SOURCE iCAD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
2. Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
3. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
4. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
5. Spectral appoints Anthony Bihl to Board of Directors
6. Tianyin Pharmaceutical Appoints Three New Independent Board Members
7. Hiemstra Appoints Robert C. Glines as Director of Business Development
8. Tengion Appoints Jeff Randall to Board of Directors
9. Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
10. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
11. Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Bed bug cases tend to increase during summer. And ... risk of becoming the pests' next victim throughout the season, ... the guide, the company enumerated the steps of getting ... , According to My Cleaning Products, there are two ... during summer: the warm weather and the rise in travel. ...
(Date:5/24/2013)... 2013 The Oklahoma tornado left ... ravage, the mayor of Moore, one of the heavily damaged ... a report from cnn.com. Reaching out to also be of ... and Safe Shield to counter the looming mold problem. , ... May 22, 2013, caused 24 deaths, My Cleaning Products shared. ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... , May 23, 2013 PuraMed BioScience ... and marketer of over-the-counter (OTC) medicinal and healthcare ... opinion on the company based on low market ... , Non-Prescription, All Natural Product to Treat Migraine ... Outperforms #1 Prescription Competitor , Currently Available ...
Breaking Biology Technology:Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
... EDT , EAST BRUNSWICK, N.J., May 6 Savient Pharmaceuticals, ... the three months ended March 31, 2009. For the first ... million, or $0.41 per basic and diluted share, on total revenues ... or $0.33 per basic and diluted share on total revenues of ...
... Therapeutics (Nasdaq: NKTR ) today reported its financial ... loss for the quarter ended March 31, 2009 was $31.8 ... $40.7 million or $0.44 per share in the first quarter ... efficiencies as compared to a year ago. Total operating costs ...
... U.S. President Bill Clinton will,participate as one of the main ... 1 and 3 in Sao Paulo, Brazil. The event is ... of the most,important gatherings focused on biofuels in the world. ... Democratic president awarded a second term,in six decades. After leaving ...
Cached Biology Technology:Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 2Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 3Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 4Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 5Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 6Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 7Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 8Savient Pharmaceuticals Reports First Quarter 2009 Financial Results 9Nektar Therapeutics Reports First Quarter 2009 Financial Results 2Nektar Therapeutics Reports First Quarter 2009 Financial Results 3Nektar Therapeutics Reports First Quarter 2009 Financial Results 4Nektar Therapeutics Reports First Quarter 2009 Financial Results 5Nektar Therapeutics Reports First Quarter 2009 Financial Results 6Nektar Therapeutics Reports First Quarter 2009 Financial Results 7Nektar Therapeutics Reports First Quarter 2009 Financial Results 8Nektar Therapeutics Reports First Quarter 2009 Financial Results 9President Bill Clinton to Speak at the Ethanol Summit in Brazil 2
(Date:5/23/2013)... or harsh treatments because science fails to identify ... the disease. Researchers at Case Western Reserve University ... that allows patients to safely choose to do ... drastic measures. , The project is one of ... engineering at Case Western Reserve and director of ...
(Date:5/23/2013)... the team reveal the interplay of brain chemicals which ... Wellcome Trust and BBSRC. , By changing the ... perceptual abilities. While these changes can affect the strength ... fidelity of that response. , Lead author ... communicate with others, you can make yourself better heard ...
(Date:5/22/2013)... have developed a novel technique that can detect molecular ... that is one of the most important, though time-consuming, ... a paper in Nature , post-doctoral researcher David ... Schnell of the Center for Free-Electron Laser Science (CFEL) ... finely-tuned microwave fields to identify molecular variants apart, and ...
Breaking Biology News(10 mins):Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3Detecting mirror molecules 2Detecting mirror molecules 3
... discovered how the toxoplasmosis parasite may trigger the development ... from the University of Leeds, Faculty of Biological Sciences ... role in the development of these disorders by affecting ... messages in the brain controlling aspects of movement, cognition ...
... University Life Sciences researchers have discovered a new mechanism ... cells, which could lead to the development of a ... is transmitted to humans through bites from mosquitoes. According ... 350 million and 500 million cases of malaria occur ...
... Strosberg of Scripps Florida, was published on March 4, 2009, ... edition, Papers in Press. In the new study, ... more amino acids) derived from the core protein of hepatitis ... dimerization of the core protein (the joining of two identical ...
Cached Biology News:Research supports toxoplasmosis link to schizophrenia 2Researchers identify new way the malaria parasite and red blood cells interact 2Scripps research team identifies key molecules that inhibit viral production 2Scripps research team identifies key molecules that inhibit viral production 3
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
... This DuoSet ELISA Development kit contains ... of sandwich ELISAs to measure natural and ... culture supernates and serum. Each kit contains ... fifteen 96-well plates, provided that the following ...
HIV-1 TAT (vN-21)...
Presenilin-1, N-terminus....
Biology Products: